PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18953944-10	2008	Thalidomide (40 microg/ml) could inhibit the release of HMGB1 in the monocytes from RA patients stimulated with TNFalpha (P < 0.05).	Thalidomide	0-11	high mobility group box 1	Homo sapiens	56-61	
18953944-12	2008	Treatment with TNFalpha (100 ng/ml) for 24 hours resulted in a cytoplasmic translocation of HMGB1, which was inhibited significantly by thalidomide.	Thalidomide	136-147	high mobility group box 1	Homo sapiens	92-97	
18953944-13	2008	CONCLUSION: TNFalpha induces the release and cytoplasmic translocation of HMGB1 in the peripheral blood monocytes of RA patients and thalidomide inhibits the release and translocation of HMGB1.	Thalidomide	133-144	high mobility group box 1	Homo sapiens	74-79	
18953944-13	2008	CONCLUSION: TNFalpha induces the release and cytoplasmic translocation of HMGB1 in the peripheral blood monocytes of RA patients and thalidomide inhibits the release and translocation of HMGB1.	Thalidomide	133-144	high mobility group box 1	Homo sapiens	187-192	
18953944-1	2008	OBJECTIVE: To investigate the release and intracellular localization of high mobility group box chromosomal protein 1 (HMGB1) in the peripheral blood monocytes of rheumatoid arthritis (RA) patients and the inhibitive effect of thalidomide.	Thalidomide	227-238	high mobility group box 1	Homo sapiens	119-124